James Stambaugh is VP at Intersect ENT, Inc. (XENT). They have made 4 open-market trades across 1 company since 2015, most recently 2016-09-06.
CIK 0001271214
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XENT | 23,700 | $669K |
Shares reported on the most recent Form 4, priced at the 2016-09-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XENT | SELL | 2016-09-02 | 2016-09-07 | $16.00 | $64K | -5.5% | +4.0% | -37.3% |
| XENT | SELL | 2016-08-03 | 2016-08-05 | $17.00 | $68K | -4.1% | +3.3% | -39.1% |
| XENT | SELL | 2016-07-18 | 2016-07-19 | $15.33 | $77K | -0.1% | -8.4% | +8.5% |
| XENT | SELL | 2016-06-13 | 2016-06-14 | $14.38 | $7K | -10.7% | -5.8% | +4.2% |
| XENT | SELL · 10b5-1 | 2015-07-20 | 2015-07-21 | $30.52 | $366K | -14.6% | -3.7% | -3.7% |
| XENT | SELL · 10b5-1 | 2015-05-08 | 2015-05-11 | $23.87 | $66K | -14.6% | -3.7% | -3.7% |
| XENT | SELL · 10b5-1 | 2015-04-01 | 2015-04-02 | $25.50 | $213K | -14.6% | -3.7% | -3.7% |
| XENT | SELL · 10b5-1 | 2015-03-09 | 2015-03-11 | $23.02 | $192K | -14.6% | -3.7% | -3.7% |
| XENT | SELL · 10b5-1 | 2015-02-02 | 2015-02-03 | $20.98 | $175K | -14.6% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.